ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Pharmaceutical Intermediate/Fmoc-S-acetamidomethyl-L-cysteine
C21H22N2O5S
414.5 g/mol
Pharmaceutical IntermediateWarning

Fmoc-cys (acm)

CAS86060-81-3
Category
Pharmaceutical Intermediate
Compound Class
Peptide
Primary Use
Pharmaceutical Intermediate

Fmoc-cys (acm) is a side-chain protected amino acid derivative used in solid-phase peptide synthesis. The Fmoc group protects the alpha-amino group while the acetamidomethyl (acm) group protects the thiol side chain of cysteine, enabling selective deprotection during peptide assembly.

side-chain protected amino acid for peptide synthesisbuilding block in solid-phase peptide synthesisresearch reagent for peptide chemistry

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing Fmoc-cys (acm)?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

SimilarStructure SimilarSimilarity 0.74

Fmoc-S-Methyl-L-Cysteine

CAS138021-87-1

research compound

ReferenceSame Category

N'-Fmoc-N-Cbz-L-Lysine

CAS86060-82-4

pharmaceutical intermediate

ReferenceSame Category

(S)-(+)-3-Hydroxytetrahydrofuran

CAS86087-23-2

pharmaceutical intermediate

ReferenceSame Category

(R)-2-Amino-3-methoxypropanoic acid hydrochloride

CAS86118-10-7

pharmaceutical intermediate

ReferenceSame Category

Boc-O-Methyl-D-serine

CAS86123-95-7

pharmaceutical intermediate

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more

Safety Reference

Harmful
Harmful
Warning
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation

Customs Tariff Classification

The international HS code for Fmoc-cys (acm) (CAS 86060-81-3) is 2930.90.

HS code (international, 6-digit)

2930.90

EU CN code (8-digit)

2930 90 16

Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.

Identifiers
IUPAC Name

(2R)-3-(acetamidomethylsulfanyl)-2-(9H-fluoren-9-ylmethoxycarbonylamino)propanoic acid

InChIKey

CSMYOORPUGPKAP-IBGZPJMESA-N

SMILES

CC(=O)NCSC[C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13

Synonyms (20)
  • Fmoc-Cys(Acm)-OH
  • Fmoc-S-acetamidomethyl-cys
  • Fmoc-cys (acm)
  • fmoc-l-cys(acm)-oh
  • fmoc-l-cysteine(acm)

Sourcing Fmoc-cys (acm)?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→